Respiratory Syncytial Virus in Older Adults: Understanding Risk, Diagnosis, and Evolving Prevention Strategies

There is a growing recognition of the effects of RSV among older adults, particularly those in long-term care facilities. Here’s my take on how preventing transmission can save millions in healthcare costs.

Elliott Bosco, PharmD, PhD Released: August 11, 2021

Vaccines are at the forefront of the national consciousness, and manufacturers of the highly effective COVID-19 vaccines have entered the race to find an effective RSV vaccine.

Spencer H. Durham, PharmD, BCPS, BCIDP Released: October 28, 2021

The potential availability of an effective RSV vaccine for older individuals is on the horizon, and with it comes numerous ways to address vaccine hesitancy in this patient population.

Barbara Resnick, PhD, CRNP Released: January 12, 2022

We are closer than ever to finding an effective RSV vaccine, but recent challenges may delay approval.

Angela Branche, MD Released: April 7, 2022